Jan 5, 2012
Here are some excerpts from the CDC Clinical Reminder. The entire bulletin can be found at http://www.cdc.gov/injectionsafety/clinical-reminders/insulin-pens.html
The Centers for Disease Control and Prevention (CDC) has become increasingly aware of reports of improper use of insulin pens, which places individuals at risk of infection with pathogens including hepatitis viruses and human immunodeficiency virus (HIV). This notice serves as a reminder that insulin pens must never be used on more than one person.
Insulin pens must never be used for more than one person. Regurgitation of blood into the insulin cartridge can occur after injection creating a risk of bloodborne pathogen transmission if the pen is used for more than one person, even when the needle is changed.
Recommendations by CDC
Anyone using insulin pens should review the following recommendations to ensure that they are not placing persons in their care at risk for infection.
·Insulin pens containing multiple doses of insulin are meant for use on a single person only, and should never be used for more than one person, even when the needle is changed.
·Insulin pens should be clearly labeled with the person’s name or other identifying information to ensure that the correct pen is used only on the correct individual.
·Hospitals and other facilities should review their policies and educate their staff regarding safe use of insulin pens and similar devices.
·If reuse is identified, exposed persons should be promptly notified and offered appropriate follow-up including bloodborne pathogen testing.
These recommendations apply to any setting where insulin pens are used, including assisted living or residential care facilities, skilled nursing facilities, clinics, health fairs, shelters, detention facilities, senior centers, schools, and camps as well as licensed healthcare facilities. Protection from infections, including bloodborne pathogens, is a basic expectation anywhere healthcare is provided. Use of insulin pens for more than one person, like other forms of syringe reuse [4], imposes unacceptable risks and should be considered a 'never event'.
Jan 5, 2012 http://www.cdc.gov/injectionsafety/clinical-reminders/insulin-pens.html